Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Perdok

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Acta Psychologica|March 1, 1980
Slow brain potentials in the CNV-paradigmA W Gaillard, J Perdok
Biological Psychology|May 1, 1979
The terminal CNV and stimulus discriminability in motor and sensory tasksJ Perdok, A W Gaillard
Acta Psychologica|May 1, 1979
Slow cortical and heart rate correlates of discrimination performanceA W Gaillard, J Perdok
Progress in Brain Research|January 1, 1980
Motor preparation at a cortical and at a peripheral levelA W Gaillard, J Perdok, C A Varey
International Archives of Allergy and Immunology|May 1, 1997
Mouse/human chimeric antibodies directed to two nonoverlapping epitopes of the house dust mite allergen, Der p 2J Schuurman, G J Perdok, R C Aalberse
Molecular Immunology|August 3, 2001
The inter-heavy chain disulfide bonds of IgG4 are in equilibrium with intra-chain disulfide bondsJ Schuurman, G J Perdok, A D Gorter, et al.
The Journal of Allergy and Clinical Immunology|April 3, 1998
Complementation of Der P 2-induced histamine release from human basophils sensitized with monoclonal IgE: not only by IgE, but also by IgG antibodies directed to a nonoverlapping epitope of Der p 2J Schuurman, G J Perdok, G A Mueller, et al.
International Archives of Allergy and Immunology|May 1, 1995
Mouse/human chimeric IgE antibodies directed to the house dust mite allergen Der p 2J Schuurman, T E Lourens, G J Perdok, et al.
Annals of the Rheumatic Diseases|October 19, 2006
Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis TrialD D Gladman, P J Mease, M A Cifaldi, et al.
Journal of the American Academy of Dermatology|December 15, 2010
Efficacy and safety of ABT-874, a monoclonal anti-interleukin 12/23 antibody, for the treatment of chronic plaque psoriasis: 36-week observation/retreatment and 60-week open-label extension phases of a randomized phase II trialAlexa B Kimball, Kenneth B Gordon, Richard G Langley, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Acta Psychologica|March 1, 1980
Slow brain potentials in the CNV-paradigmA W Gaillard, J Perdok
Biological Psychology|May 1, 1979
The terminal CNV and stimulus discriminability in motor and sensory tasksJ Perdok, A W Gaillard
Acta Psychologica|May 1, 1979
Slow cortical and heart rate correlates of discrimination performanceA W Gaillard, J Perdok
Progress in Brain Research|January 1, 1980
Motor preparation at a cortical and at a peripheral levelA W Gaillard, J Perdok, C A Varey
International Archives of Allergy and Immunology|May 1, 1997
Mouse/human chimeric antibodies directed to two nonoverlapping epitopes of the house dust mite allergen, Der p 2J Schuurman, G J Perdok, R C Aalberse
Molecular Immunology|August 3, 2001
The inter-heavy chain disulfide bonds of IgG4 are in equilibrium with intra-chain disulfide bondsJ Schuurman, G J Perdok, A D Gorter, et al.
The Journal of Allergy and Clinical Immunology|April 3, 1998
Complementation of Der P 2-induced histamine release from human basophils sensitized with monoclonal IgE: not only by IgE, but also by IgG antibodies directed to a nonoverlapping epitope of Der p 2J Schuurman, G J Perdok, G A Mueller, et al.
International Archives of Allergy and Immunology|May 1, 1995
Mouse/human chimeric IgE antibodies directed to the house dust mite allergen Der p 2J Schuurman, T E Lourens, G J Perdok, et al.
Annals of the Rheumatic Diseases|October 19, 2006
Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis TrialD D Gladman, P J Mease, M A Cifaldi, et al.
Journal of the American Academy of Dermatology|December 15, 2010
Efficacy and safety of ABT-874, a monoclonal anti-interleukin 12/23 antibody, for the treatment of chronic plaque psoriasis: 36-week observation/retreatment and 60-week open-label extension phases of a randomized phase II trialAlexa B Kimball, Kenneth B Gordon, Richard G Langley, et al.
Pageof 3